Cargando…
L-arginine supplementation reduces mortality and improves disease outcome in mice infected with Trypanosoma cruzi
Chagas disease caused by Trypanosoma cruzi is a neglected disease that affects about 7 million people in Latin America, recently emerging on other continents due to migration. As infection in mice is characterized by depletion of plasma L-arginine, the effect on infection outcome was tested in mice...
Autores principales: | Carbajosa, Sofía, Rodríguez-Angulo, Héctor O., Gea, Susana, Chillón-Marinas, Carlos, Poveda, Cristina, Maza, María C., Colombet, Diana, Fresno, Manuel, Gironès, Núria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786330/ https://www.ncbi.nlm.nih.gov/pubmed/29337988 http://dx.doi.org/10.1371/journal.pntd.0006179 |
Ejemplares similares
-
Global Metabolomic Profiling of Acute Myocarditis Caused by Trypanosoma cruzi Infection
por: Gironès, Núria, et al.
Publicado: (2014) -
Altered bone marrow lymphopoiesis and interleukin-6-dependent inhibition of thymocyte differentiation contribute to thymic atrophy during Trypanosoma cruzi infection
por: Carbajosa, Sofía, et al.
Publicado: (2017) -
Analysis of the Dynamics of Infiltrating CD4(+) T Cell Subsets in the Heart during Experimental Trypanosoma cruzi Infection
por: Sanoja, Cristina, et al.
Publicado: (2013) -
Interaction of Signaling Lymphocytic Activation Molecule Family 1 (SLAMF1) receptor with Trypanosoma cruzi is strain-dependent and affects NADPH oxidase expression and activity
por: Poveda, Cristina, et al.
Publicado: (2020) -
Cyclooxygenase-2 and Prostaglandin E(2) Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection
por: Guerrero, Néstor A., et al.
Publicado: (2015)